Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00908947 · ClinicalTrials.gov registry record · NA
CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM")
A NA study, sponsored by C. R. Bard.
- Terminated
- Registry status
- NA
- Development phase
- 173
- Enrollment target
NCT00908947: Clinical Trial NA study, sponsored by C. R. Bard.
NCT00908947 is a NA study that was terminated before completion, run by C. R. Bard. The registered enrollment target is 173 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00908947, a NA study, was terminated before completion, sponsored by C. R. Bard.
- TERMINATED
- Registry status
- NA
- Development phase
- 173 participants
- Enrollment target
Study Summary
The objectives of this study are to collect post-market confirmatory evidence of the safety and effectiveness of the Bard® LifeStent® Vascular Stent System and LifeStent® XL Vascular Stent System (together the "LifeStent® Vascular Stent System").
Primary Outcome
Primary safety endpoint defined as freedom from occurrence of death at 30-days and 12-months post-index procedure.
Interventions
- DEVICE PTA followed by placement of LifeStent® Vascular Stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 173 participants |
| Start Date | 2011-02 |
| Est. Completion | 2018-09-19 |
| Phase | NA |
Why NCT00908947 stopped before completion
NCT00908947 is an interventional study that assigns participants to a tested intervention. The registered 173 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 1 intervention - of which PTA followed by placement of LifeStent® Vascular Stent is the first listed.
NCT00908947 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00908947 about?
NCT00908947 is a clinical study titled "CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM")". The objectives of this study are to collect post-market confirmatory evidence of the safety and effectiveness of the Bard® LifeStent® Vascular Stent System and LifeStent® XL Vascular Stent System (together the "LifeStent® Vascular Stent System").
What is the current status of trial NCT00908947?
This trial is currently terminated. It is a NA study. The enrollment target is 173 participants. The study started on 2011-02. Estimated completion is 2018-09-19.
What interventions are being tested in trial NCT00908947?
The interventions under investigation include: PTA followed by placement of LifeStent® Vascular Stent (DEVICE).
Who is sponsoring clinical trial NCT00908947?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00908947's enrollment target sits among peer trials
173 611th of 2000 higher than 1,389 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05568719 · 173 participants · Phase 3
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- NCT07070115 · 173 participants · NA
Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®
- NCT07150832 · 173 participants · NA
Efficacy of the I-CARE Digital Health Intervention
- NCT01000259 · 174 participants
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia